Springbok Therapeutics®

The Springbok is an organized and graceful animal. Springbok Therapeutics is seeking to address unmet medical needs for Neglected Tropical Diseases, gracefully. The strategy involves opportunities for the originator of the molecule to benefit in PR and other substantial returns. The firm is licensing clinical molecules from large pharma to develop and register for use by patients who need them. With our expertise we can match address those needs competently and in an accelerated manner.

Springbok TherapeuticsTM welcomes contact from governments with Neglected Tropical Diseases that have resources to develop new molecules to treat those diseases.

Springbok Therapeutics also provides advice at the governmental and public health level, particularly as this relates to the use of vaccines, conduct of population and other clinical trials.